halofantrine has been researched along with Bradycardia in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barratt, G; Grabe-Guimarães, A; Guimarães, HN; Leite, EA; Machado-Coelho, GL; Mosqueira, VC | 1 |
Bunnag, D; Harinasuta, T; Karbwang, J; Laothavorn, P; Na Bangchang, K | 1 |
Gendrel, D; Imbert, P; Lavallée, I; Marc, E; Moulin, F; Treluyer, JM | 1 |
3 other study(ies) available for halofantrine and Bradycardia
Article | Year |
---|---|
Cardiotoxicity reduction induced by halofantrine entrapped in nanocapsule devices.
Topics: Animals; Antimalarials; Bradycardia; Disease Models, Animal; Dose-Response Relationship, Drug; Electrocardiography; Heart; Hypotension; Lethal Dose 50; Long QT Syndrome; Malaria; Male; Mice; Nanocapsules; Phenanthrenes; Plasmodium berghei; Rats; Rats, Wistar | 2007 |
Cardiac effect of halofantrine.
Topics: Adolescent; Adult; Antimalarials; Arrhythmias, Cardiac; Bradycardia; Electrocardiography; Heart; Heart Block; Humans; Malaria, Falciparum; Male; Middle Aged; Phenanthrenes | 1993 |
[Cardiac rhythm disturbances and prolonged QT interval with halofantrine].
Topics: Adolescent; Antimalarials; Bradycardia; Child; Child, Preschool; Electrocardiography; Female; Humans; Infant; Long QT Syndrome; Malaria; Male; Phenanthrenes | 2001 |